Drugs in the making.com
Dr.Shruti Bhat, Star formulator and Ace leader within pharmaceutical R&D, a specialist with hiTech formulations and quality-by-design. Shruti brings to you some highlights from current pharma and clinical research news, views and data.
Glaxo R&D changes R&D model : Group Aims To Develop Drugs Like Small Biotech Companies.
The Wall Street Journal reported that GlaxoSmithKline has turned its research and development group into a number of specialized teams that aim to discover drugs in a similar way to biotechnology companies. The teams, known as discovery performance units, or DPUs, are about halfway through the three-year budgets they were given in 2008, and the company has notified them that if they don't produce, there will be layoffs. The company has also reduced its R&D staff by about 20% since 2006, and increased its investment in outside research firms.
Europeans Said To Be Skeptical Of Flu Vaccines.
The Financial Times reported that Europeans are skeptical of flu vaccines. Thus, drug companies predict, there will be no increase in demand for the vaccines across the European Union. But drugmakers are expecting increased sales in the US. The Times also notes that EU citizens may have greater protection from the seasonal flu than those in the US because the EU uses adjuvanted vaccines.
More pharmaceutical research updates at http://www.pharm-education.com/2010/07/dengue-returns-to-us-sanofi-sees-phase.html
Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
Expert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.
YouTube Channel : Http://www.youtube.com/user/ShrutiBhat10
Do you have questions for the author?
Dr. Shruti Bhat
Pharmaceutical Manufacturing, Continuous Improvement and Business Transformation Consultant
New Release !
The information posted here, not limited to blogs, website, podcasts, videos, eBooks, whitepapers and other 'free' resources including downloaded items are Copyright protected, 'for review' purpose only. Not to be copied, distributed or used without prior written authorization by Dr. Shruti U. Bhat. Any instance(s) found to the contrary would be construed as copyright violation, illegal, plagiarism and/or could be subject to legal proceedings.
For additional details, refer our Terms & Conditions for site usage.
Kaizen book at # 4 on Amazon Best Sellers List!